APA (7th ed.) Citation

Quodbach, J., Bogdahn, M., Breitkreutz, J., Chamberlain, R., Eggenreich, K., Elia, A. G., . . . Spitz, T. (2022). Quality of FDM 3D Printed Medicines for Pediatrics: Considerations for Formulation Development, Filament Extrusion, Printing Process and Printer Design. Therapeutic innovation & regulatory science, 56(6), 910-928. https://doi.org/10.1007/s43441-021-00354-0

Chicago Style (17th ed.) Citation

Quodbach, Julian, et al. "Quality of FDM 3D Printed Medicines for Pediatrics: Considerations for Formulation Development, Filament Extrusion, Printing Process and Printer Design." Therapeutic Innovation & Regulatory Science 56, no. 6 (2022): 910-928. https://doi.org/10.1007/s43441-021-00354-0.

MLA (9th ed.) Citation

Quodbach, Julian, et al. "Quality of FDM 3D Printed Medicines for Pediatrics: Considerations for Formulation Development, Filament Extrusion, Printing Process and Printer Design." Therapeutic Innovation & Regulatory Science, vol. 56, no. 6, 2022, pp. 910-928, https://doi.org/10.1007/s43441-021-00354-0.